checkAd

    EQS-Adhoc  498  0 Kommentare LifeWatch AG: FDA clearance for continuous Vital Signs Monitoring Service - Seite 3


    SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
    GENERAL
    CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
    OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
    THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
    SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
    ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
    REGISTERED UNDER THE UNITED STATES
    SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED
    STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE
    EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
    SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
    STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM
    LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
    INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
    STATEMENTS OF THE ISSUER.

    End of ad hoc announcement

    +++++
    Additional features:

    Document: http://n.eqs.com/c/fncls.ssp?u=SOCCCRLJKY
    Document title: LifeWatch(TM) receives FDA clearance for its continuous
    Vital Signs Monitoring Service

    ---------------------------------------------------------------------------

    09.02.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive:
    http://switzerland.eqs.com/de/News

    The issuer is responsible for the contents of the release.

    ---------------------------------------------------------------------------


    Language: English
    Company: LifeWatch AG
    Baarerstrasse 139
    6300 Zug
    Switzerland
    Phone: +41 41 728 67 78
    Internet: www.lifewatch.com
    ISIN: CH0012815459
    Valor: 811189
    Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open
    Market in Frankfurt ; SIX


    End of News EQS Group News Service
    ---------------------------------------------------------------------------

    435611 09.02.2016
    Seite 3 von 3




    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc LifeWatch AG: FDA clearance for continuous Vital Signs Monitoring Service - Seite 3 EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Regulatory Approval LifeWatch AG: FDA clearance for continuous Vital Signs Monitoring Service 09.02.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible …